DAVID ALLGOOD: Open Payments
NPI 1851364335 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 24 payments from 12 companies in 2025. Trend: 2023 $244 · 2024 $379 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Amgen Inc. | 2 | $30 |
| Medtronic, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: Wegovy, TRELEGY ELLIPTA, GEMTESA, BREZTRI, The Cologuard Plus Collection Kit, MOUNJARO, OTEZLA, INCEPTIV.
Industry payments across NC — which companies pay providers there.
